Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.08 CAD | +0.84% | +1.09% | +23.93% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.18% | 299B | |
+11.86% | 151B | |
+41.69% | 115B | |
+21.25% | 82.14B | |
+11.47% | 77.02B | |
+22.31% | 63.9B | |
+12.86% | 59.39B | |
+8.87% | 47.98B | |
+31.78% | 36.15B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Ovintiv : Kept at Sector Perform at RBC Capital Markets Following "Buoyant" First-Quarter Results